Výsledky vyhledávání - "MARIO MOTOLESE"

Intravascular ultrasound and quantitative coronary angiography assessment of late in-stent restenosis: In vivo human correlation and methodological implications

Autor: Mario Motolese, Antonella Labellarte, Tomasz Pawłowski, Francesco Prati, Luigi Sommariva, Alessandro Manzoli, Alessandro Boccanelli

Publikováno v: Catheterization and Cardiovascular Interventions. 57:155-160

Quantitative coronary angiography (QCA) is routinely used for assessment of strategies aimed at reducing in-stent restenosis. Yet QCA enables only the measurement of luminal variation of stented segments and, unlike intravascular ultrasound (IVUS), p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a112a8880509d9f7786a25e526d456d
https://doi.org/10.1002/ccd.10298

Zobrazit plný text záznamu

Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency

Autor: Daniele Alberti, Pietro Zucchelli, Eberhard Ritz, Giuseppe Maschio, Mario Motolese, Johannes F.E. Mann, Gérard Janin, Claudio Ponticelli, Francesco Locatelli

Publikováno v: New England Journal of Medicine. 334:939-945

Background Drugs that inhibit angiotensin-converting enzyme slow the progression of renal insufficiency in patients with diabetic nephropathy. Whether these drugs have a similar action in patients with other renal diseases is not known. We conducted

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e2b8a13cda1495e717b147681cea31a1
https://doi.org/10.1056/nejm199604113341502

Zobrazit plný text záznamu

Evaluation by 24-Hour Ambulatory Blood Pressure Monitoring of Efficacy of Benazepril 20 mg Plus Hydrochlorothiazide 25 mg Fixed Combination as Compared to Captopril 25 mg Plus Hydrochlorothiazide 25 mg Fixed Combination in Treating Mild to Moderate Hypertension

Autor: Annalisa Zoppi, Paola Lusardi, F. Tettamanti, Roberto Fogari, Mario Motolese, Daniela Tettamanzi

Publikováno v: Journal of Cardiovascular Pharmacology. 24:687-693

In a double-blind, placebo-controlled, three-period cross-over, randomized study we evaluated the efficacy and tolerability of a fixed combination of benazepril 20 mg and hydrochlorothiazide 25 mg (BN + HCT) as compared with the fixed combination of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8ce9a3160c3b3ecd94d0617e6355e30
https://doi.org/10.1097/00005344-199424050-00001

Zobrazit plný text záznamu

Prevention of Sudden Cardiac Death After a First Myocardial Infarction by Pharmacologic or Surgical Antiadrenergic Interventions

Autor: PETER J. SCHWARTZ, MARIO MOTOLESE, GIORGIO POLLAVINI, ANTONIO LOTTO, UGO RUBERTI, RINALDO TRAZZI, CESARE BARTORELLI, ALBERTO ZANCHETTI, THE ITALIAN SUDDEN DEATH PREVENTION GROUP

Publikováno v: Journal of Cardiovascular Electrophysiology. 3:2-16

Antiadrenergic Interventions and Prevention of Sudden Death after MI. Introduction: Growing evidence points to sympathetic hyperactivity as one critical trigger for life-threatening arrhythmias among postmyocardial infarction patients. Methods and Re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::692c26bdc5c4aba88c3eba88e977e5de
https://doi.org/10.1111/j.1540-8167.1992.tb01090.x

Zobrazit plný text záznamu

Riskard 2005. New tools for prediction of cardiovascular disease risk derived from Italian population studies

Autor: Antonio Vittorino Gaddi, Ada Dormi, Sandro Muntoni, Alessandro Menotti, Stefano Remiddi, G. Cavera, Mariapaola Lanti, Alberto Zanchetti, Pierluigi Prati, Mario Motolese, Sergio Muntoni, Alberto Notarbartolo, Luigi Carratelli, Mario Mancini, Enrico Agabiti-Rosei, Maria Lorenza Muiesan

Publikováno v: Nutrition, metabolism, and cardiovascular diseases : NMCD. 15(6)

Background and aim The need to update tools for the estimate of cardiovascular risk prompted the “Gruppo di Ricerca per la Stima del Rischio Cardiovascolare in Italia” to produce a new chart and new software called Riskard 2005. Methods and resul

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::565cc71be9da64b21177b6556cfce657
https://pubmed.ncbi.nlm.nih.gov/16314225

Zobrazit plný text záznamu

[Hormone replacement therapy and cardiovascular prevention: many statements, some doubts]

Autor: Mario, Motolese

Publikováno v: Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology. 4(7)

Results of randomized, placebo-controlled clinical trials with major clinical endpoints as well as with angiographic or echographic endpoints recently completed with hormone replacement therapy in postmenopausal women, are critically discussed. These

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2b09cf908d7476fc9d3859cb545344a6
https://pubmed.ncbi.nlm.nih.gov/14558283

Zobrazit plný text záznamu

Benazepril causes in hypertension a greater reduction in left ventricular mass than does nitrendipine: a randomized study using magnetic resonance imaging

Autor: F. M. Ferri, P. P. Campa, S. Villatico Campbell, Carlo Gaudio, F. Bertocchi, Gaetano Tanzilli, Mario Motolese

Publikováno v: Journal of cardiovascular pharmacology. 32(5)

To assess the comparative effects of benazepril and nitrendipine monotherapies on left ventricular mass index (LVMI) in hypertensive patients with echocardiographically determined left ventricular hypertrophy, patients with diastolic blood pressure (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9aca83ed867bad7bf9d486354bc8d01c
https://pubmed.ncbi.nlm.nih.gov/9821850

Zobrazit plný text záznamu

Fixed combination of benazepril and low-dose amlodipine in the treatment of mild to moderate essential hypertension: evaluation by 24-hour noninvasive ambulatory blood pressure monitoring

Autor: Paola Lusardi, Paola Preti, Amedeo Mugellini, Mario Motolese, Roberto Fogari, Annalisa Zoppi

Publikováno v: Journal of cardiovascular pharmacology. 30(2)

The antihypertensive efficacy and tolerability of a fixed combination of benazepril (10 mg) and low-dose amlodipine (2.5 mg) were assessed in 24 patients (mean age, 43.9 years) with uncomplicated mild to moderate essential hypertension [supine diasto

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62f57547bcc4c393924c451095c1a48c
https://pubmed.ncbi.nlm.nih.gov/9269944

Zobrazit plný text záznamu

Effects of the Calcium Antagonist Felodipine on Resting and Stress Testing Blood Pressure in Essential Hypertension

Autor: Umberto Campia, Mario Motolese, Carmine Cardillo, Nadia Mores, G Folli, V. Musumeci

Publikováno v: American journal of therapeutics. 1(3)

The current study analyzed the effects of different doses of the calcium channel blocker felodipine on cardiovascular response to a set of standardized laboratory tasks. We randomly allocated 21 essential hypertensive patients to receive extended rel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7845de6c2f27e3fe742b64b4a047ac0b
https://pubmed.ncbi.nlm.nih.gov/11835087

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání